試題詳解

69. 依據 2023 AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma，下列何者敘述正確？
(1) AASLD does not advise use of statins, aspirin, and metformin solely to
reduce HCC risk
(2) AASLD recommends against routine use of HCC surveillance in patients
with NAFLD who have advanced fibrosis but without cirrhosis
(3) AASLD advises repeat short-interval ultrasound and AFP in approximately3-6 months for patients with a ＜1 cm lesion on abdominal ultrasound
(4) In patients with an LI-RADS-4 observation, AASLD advises repeat
cross-sectional imaging in 3–6 months
(A) (3)＋(4)
(B) (1)＋(2)
(C) (3)
(D) (1)＋(2)＋(3)

(E) (1)＋(2)＋(3)＋(4)